|1.||Karginov, Vladimir A: 5 articles (01/2010 - 01/2006)|
|2.||Robinson, Tanisha M: 4 articles (06/2008 - 01/2006)|
|3.||Ares-Mazás, E: 4 articles (02/2002 - 10/2000)|
|4.||Castro-Hermida, J A: 4 articles (02/2002 - 10/2000)|
|5.||Freire-Santos, F: 4 articles (02/2002 - 10/2000)|
|6.||Yohannes, Adiamseged: 3 articles (08/2007 - 01/2006)|
|7.||Fahmi, Nour Eddine: 3 articles (08/2007 - 01/2006)|
|8.||Hecht, Sidney M: 3 articles (08/2007 - 01/2006)|
|9.||Burhenne, Jürgen: 2 articles (07/2010 - 01/2006)|
|10.||Durán, Nelson: 2 articles (02/2010 - 04/2003)|
07/01/1999 - "Pain relief was significantly greater (p < 0.05) and more rapid with nimesulide beta cyclodextrin. "
01/01/2009 - "The objective of this study was to determine whether the temperature of Cerenia alters binding between maropitant and sulphobutylether-beta-cyclodextrin and affects injection pain. "
05/01/2003 - "Efficacy and tolerability of conventional nimesulide versus Beta-cyclodextrin nimesulide in patients with pain after surgical dental extraction: a multicenter, prospective, randomized, double-blind, double-dummy study."
07/01/1999 - "Both study drugs were effective and well tolerated in the treatment of acute dental pain, with nimesulide beta cyclodextrin showing a faster onset of analgesic action."
07/01/1999 - "This was a randomised, double-blind, between-patient, multicentre study involving 148 outpatients suffering from moderate to severe pain, who received single doses of either 400 mg nimesulide beta cyclodextrin or 100 mg nimesulide. "
06/01/2008 - "In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin."
11/01/2006 - "In the present study, we evaluate a series of new beta-cyclodextrin derivatives with the goal of identifying potent inhibitors of anthrax toxins. "
01/01/2006 - "Several beta-cyclodextrin derivatives were evaluated for their ability to protect RAW 264.7 cells from the action of anthrax lethal toxin. "
01/01/2006 - "Beta-cyclodextrin derivatives that inhibit anthrax lethal toxin."
08/15/2007 - "Recently, we demonstrated that derivatives of beta-cyclodextrin inhibited anthrax lethal toxin (LeTx) action by blocking the transmembrane pore formed by the protective antigen (PA) subunit of the toxin. "
02/01/2002 - "The efficacy of beta-cyclodextrin against experimental Cryptosporidium parvum infection was evaluated in neonatal lambs. "
11/05/2001 - "The effectiveness of beta-cyclodextrin, excipient used in pharmaceutical industry, in the treatment of natural infection by Cryptosporidium parvum in suckling calves, was evaluated. "
08/01/2001 - "Following the unexpected activity of the excipient beta-cyclodextrin against experimental infection by Cryptosporidium parvum in suckling mice, its efficacy in the prevention and treatment of natural infections in lambs was evaluated under field conditions. "
08/01/2001 - "Treatment with beta-cyclodextrin of natural Cryptosporidium parvum infections in lambs under field conditions."
06/01/2001 - "The level of infection in treated mice was significantly lower than in control mice and, surprisingly, the most efficacious treatment was beta-cyclodextrin, an excipient used in pharmaceutical technology."
01/22/2008 - "The composition comprising the highly water-soluble drug meglumine antimoniate (MA) and beta-cyclodextrin (beta-CD) was shown previously to enhance the absorption of Sb by oral route and render MA orally active in a murine model of cutaneous leishmaniasis. "
01/01/2004 - "In this work, we investigated the ability of beta-cyclodextrin to enhance the oral absorption of antimony and to promote the oral efficacy of meglumine antimoniate against experimental cutaneous leishmaniasis. "
|3.||Renal Replacement Therapy (Therapies, Renal Replacement)
|5.||Fluid Therapy (Oral Rehydration Therapy)